Brasília – Lawsuits filed against private health insurers in Brazil could reach between 900,000 and 1.2 million new cases per year by 2035, according to projections from the Instituto de Estudos de Saúde Suplementar (IESS). The study shows a 112% increase in litigation between 2020 and 2024, driven by regulatory gaps, communication failures between beneficiaries and insurers, and economic incentives that favor legal action.

The rapid escalation of disputes — often involving access to medicines, coverage of hospital treatments, and premium adjustments — raises concerns about the financial stability of the supplementary health system. The IESS highlights potential mitigation strategies, including expanding mediation mechanisms, improving regulatory transparency, and strengthening technical support for judicial decisions.

Source: Broadcast


Need to understand Brazil’s market and political landscape?

Contact Pietro Rubin — pharmabrnews@gmail.com


Leave a Reply

Tendência

Discover more from PharmaBR.News

Subscribe now to keep reading and get access to the full archive.

Continue reading